HEMOSOL B0 Solution for haemodialysis / haemofiltration Ref.[50601] Active ingredients: Calcium chloride Lactic acid Magnesium chloride Sodium bicarbonate Sodium chloride

Source: Health Products Regulatory Authority (IE)  Revision Year: 2022  Publisher: Baxter Holding B.V., Kobaltweg 49, 3542CE Utrecht, Netherlands

5.1. Pharmacodynamic properties

Pharmacotherapeutic group: Hemofiltrates
ATC code: B05ZB

Pharmacodynamic effects

Hemosol B0 is pharmacologically inactive. The sodium, calcium, magnesium and chloride ions are present at concentrations similar to physiological levels in plasma.

Mechanism of action

The solution is used to replace water and electrolytes removed during haemofiltration or to serve as a suitable exchange medium for use during haemodiafiltration or continuous haemodialysis.Hydrogen carbonate is used as an alkalising buffer.

5.2. Pharmacokinetic properties

Not relevant. The active ingredients are pharmacologically inactive and are present at concentrations similar to physiological plasma levels.

5.3. Preclinical safety data

Not relevant. The active ingredients are pharmacologically inactive and are present at concentrations similar to physiological plasma levels.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.